Gasparian A V, Laktionov K K, Belialova M S, Pirogova N A, Tatosyan A G, Zborovskaya I B
Oncogene Regulation Laboratory, NN Blokchin Cancer Research Center of Academy of Medical Science, Moscow, Russia.
Br J Cancer. 1998 May;77(10):1604-11. doi: 10.1038/bjc.1998.263.
The mapping of allelic loss on the short arm of chromosome 1 has been performed in non-small-cell lung cancer. We used a set of 11 microsatellite loci spanning 1p to examine the frequency of allelic imbalance in a panel of 58 tumours. Fifty-one of 58 (87.9%) cases have shown somatic allelic loss at one or more loci tested. The two shortest regions of the overlap (SRO) of the deletions have been identified: SRO 1 at 1p13.1 and SRO 2 at 1p32-pter. Allelic losses at these regions have been compared among adenocarcinoma and squamous cell carcinoma and no difference has been found. In contrast to SRO 1, deletions at SRO 2 significantly correlated with advanced stage of the disease as well as post-operative metastasizing and relapse. These data may suggest that SRO 1 and SRO 2 can harbour tumour-supressor genes (TSGs) involved in different stages of NSCLC development. SRO 2 is still quite large and its refined mapping should help attempts to clone and identify the putative TSG(s). Microsatellite instability (replication errors) affecting only 6 (10.3%) of 58 tumour samples is an infrequent genetic alteration at the loci tested.
在非小细胞肺癌中已对1号染色体短臂上的等位基因缺失进行了定位。我们使用了一组跨越1p的11个微卫星位点,来检测58个肿瘤样本中等位基因失衡的频率。58例中的51例(87.9%)在一个或多个检测位点出现了体细胞等位基因缺失。已确定了缺失的两个最短重叠区域(SRO):位于1p13.1的SRO 1和位于1p32 - pter的SRO 2。对腺癌和鳞状细胞癌中这些区域的等位基因缺失情况进行了比较,未发现差异。与SRO 1不同,SRO 2处的缺失与疾病的晚期阶段以及术后转移和复发显著相关。这些数据可能表明SRO 1和SRO 2可能含有参与非小细胞肺癌不同发展阶段的肿瘤抑制基因(TSG)。SRO 2仍然相当大,对其进行精细定位应有助于克隆和鉴定假定的肿瘤抑制基因。微卫星不稳定性(复制错误)仅影响58个肿瘤样本中的6个(10.3%),在所检测的位点上是一种罕见的基因改变。